Home » Neoprobe Shares Soar on Lymphoseek Clinical Trial Results
Neoprobe Shares Soar on Lymphoseek Clinical Trial Results
Shares of Neoprobe continue their strong performance of recent weeks, rising by as much as 8 percent in early Friday trading after the company published results from a phase II clinical trial of its cancer-targeting agent.
Med City News
Med City News
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May